FdaApplication
NDA 205777
Identifiers
- fda_app_no: NDA205777
Properties
| Property | Value |
|---|---|
| applicant_name | PURDUE PHARMA LP |
| application_type | NDA |
| approval_date | 2014-07-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TARGINIQ | NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE | 20MG;40MG | TABLET, EXTENDED RELEASE;ORAL |
| TARGINIQ | NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE | 10MG;20MG | TABLET, EXTENDED RELEASE;ORAL |
| TARGINIQ | NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE | 5MG;10MG | TABLET, EXTENDED RELEASE;ORAL |
3 products